Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery

Condition:   Heart Valve Diseases Interventions:   Drug: Six percent hydroxy ethyl starch 130/0.4;   Drug: Ringer lactate Sponsors:   Rajaie Cardiovascular Medical and Research Center;   Heart Valve Disease Research Center Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials